MiR-148a regulates MEG3 in gastric cancer by targeting DNA methyltransferase 1

J Yan, X Guo, J Xia, T Shan, C Gu, Z Liang, W Zhao… - Medical oncology, 2014 - Springer
J Yan, X Guo, J Xia, T Shan, C Gu, Z Liang, W Zhao, S Jin
Medical oncology, 2014Springer
The long non-coding RNA MEG3 has been reported to be a tumor suppressor in a number
of malignant tumors including gastric cancer. Several studies have shown that the regulation
of MEG3 may attribute to the promoter hypermethylation. However, the mechanism of MEG3
regulation in gastric cancer is still not well understood. MiR-148a can suppress gastric
tumorigenesis through regulating the expression of target genes such as DNA
methyltransferase 1 (DNMT-1). We examined the expression of MEG3 in 52 gastric cancer …
Abstract
The long non-coding RNA MEG3 has been reported to be a tumor suppressor in a number of malignant tumors including gastric cancer. Several studies have shown that the regulation of MEG3 may attribute to the promoter hypermethylation. However, the mechanism of MEG3 regulation in gastric cancer is still not well understood. MiR-148a can suppress gastric tumorigenesis through regulating the expression of target genes such as DNA methyltransferase 1(DNMT-1). We examined the expression of MEG3 in 52 gastric cancer samples using quantitative real-time PCR and found the down-regulation of MEG3 in both gastric cancer tissues and cell lines. The positive correlation of MEG3 and miR-148a was further confirmed in SGC-7901 and BGC-823 gastric cancer cell lines. Hypermethylation of MEG3 differentially methylated regions was identified by methylation-specific PCR, and MEG3 expression was increased with the inhibition of methylation with siRNA to DNMT-1 in gastric cancer cells. In addition, transfection of MEG3 siRNA into gastric cancer cells diminished the suppression of proliferation induced by overexpression of miR-148a. Our results suggest that the suppression of miR-148a may contribute to the down-regulation of MEG3 in gastric cancer by modulation of DNMT-1.
Springer